Dose Prediction for Repurposing Nitazoxanide in SARS-CoV-2 Treatment or Chemoprophylaxis (2020)
Attributed to:
An Injectable Implant Providing Long-Acting Drug Delivery for the Treatment of Chronic disease
funded by
EPSRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.22541/au.158938595.50403411
Publication URI: http://dx.doi.org/10.22541/au.158938595.50403411
Type: Preprint